Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituxan and Vinorelbine in Relapsed B-Cell NHL Post-Transplant
NCT00003963Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- May 1999
- Primary completion
- Sep 2003
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, vinorelbine in B-cell non-Hodgkin lymphoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started May 1999; status: completed.
02
Drugs
rituximabvinorelbine
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00003963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003963.